Provided by Tiger Trade Technology Pte. Ltd.

DexCom

84.41
+0.11000.13%
Post-market: 84.410.00000.00%16:17 EDT
Volume:3.61M
Turnover:303.69M
Market Cap:31.85B
PE:33.28
High:84.54
Open:84.01
Low:83.08
Close:84.30
52wk High:92.59
52wk Low:54.11
Shares:377.36M
Float Shares:376.00M
Volume Ratio:1.22
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.54
EPS(LYR):2.09
ROE:38.49%
ROA:10.33%
PB:12.15
PE(LYR):40.40

Loading ...

FDA Clears First Over--Counter Continuous Glucose Monitor for Children

THOMSON REUTERS
·
Jun 13

Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction

Reuters
·
Jun 11

DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 11

TD Cowen Adjusts Price Target on DexCom to $95 From $75, Maintains Buy Rating

MT Newswires Live
·
Jun 10

TD Cowen Remains a Buy on Dexcom (DXCM)

TIPRANKS
·
Jun 10

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-06-09

Reuters
·
Jun 10

Dexcom (DXCM) Gets a Buy from Wells Fargo

TIPRANKS
·
Jun 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Revolution Medicines (RVMD) and Incyte (INCY)

TIPRANKS
·
Jun 09

Bellevue says obesity, diabetes drug market shifts focus to patient adherence at ADA 2026

Reuters
·
Jun 09

U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers

Reuters
·
Jun 09

DexCom Inc. Stock Climbs 5.2%, Outperforms Peers

Dow Jones
·
Jun 09

DexCom price target raised to $91 from $81 at Raymond James

TIPRANKS
·
Jun 09

Movement Alert|DexCom Rises 5.27% in Regular Trading, Connect Study Data Demonstrates Significant Blood Sugar Reduction With G7 Combination Therapy

Market Focus
·
Jun 08

Mizuho Securities Adjusts DexCom Price Target to $85 From $75, Maintains Outperform Rating

MT Newswires Live
·
Jun 08

DexCom announces results from CONNECT trial of Dexcom G7

TIPRANKS
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

BRIEF-Dexcom Says Use Of Dexcom G7 Leads To Improvement In Glucose Control In People With Type 2 Diabetes Not Using Insulin Versus Routine Care Control Group

Reuters
·
Jun 07

Dexcom Connect Study: the Most Significant Clinical Study Demonstrating Cgm Benefits for People With Type 2 Diabetes Not Using Insulin

THOMSON REUTERS
·
Jun 07

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

Reuters
·
Jun 07

Dexcom: Six-Month Extension Phase of Connect Randomized Controlled Trial Is Currently Being Conducted

THOMSON REUTERS
·
Jun 07